🚀 A New Journey Begins on X! 🚀
I have been actively trading and investing in the stock market since 2020, but I was never very active on X for sharing market insights.
Now, I’ve decided to change that! 📈
Going forward, I’ll be sharing:
✅ Technical Analysis
✅ IPO Reviews & Updates
✅ Swing Trading Ideas
✅ Market Insights
✅ My Real Trading Experience & Learnings
My goal is to build a community where we can learn, grow, and become better traders together. 🤝
If you’re passionate about the stock market, IPOs, and trading, follow my profile and join this journey! 🚀
Let’s build a strong trading community together 📊💙
“Trend ke saath trade karo, prediction ke saath nahi.” 💯
#StockMarket #Trading #Investing #IPO #TechnicalAnalysis #SwingTrading #IndianStockMarket #TraderCommunity #NSE #BSE #StockMarketIndia 🚀📈
⚡ Lumino Industries IPO Review
One of the most interesting Power Transmission & EPC IPOs of 2026! 🔥
🔷 IPO Size: ₹700 Cr
🔷 Price Band: ₹78 – ₹82/share
🔷 Fresh Issue: ₹500 Cr | OFS: ₹200 Cr
🔷 Lot Size: 182 Shares
🔷 Minimum Investment: ₹14,924
🔷 IPO Dates: 27–31 Aug 2026
🔷 Listing: 3 Sep 2026 🚀
🔷 GMP: ~₹45–50*
✅ Positives
• Product-driven integrated EPC player in the power sector ⚡
• Manufactures conductors, HTLS conductors, power cables & electrical wires
• Strong exposure to Power T&D, renewable energy & railways
• Impressive ₹3,149 Cr order book as of Mar 2026 📚
• FY26 Revenue: ~₹2,089 Cr
• FY26 PAT: ~₹160 Cr 📈
• FY24–FY26 revenue grew ~47%
• FY26 RoE ~24.6% & RoCE ~25.8%
• IPO proceeds include ₹337 Cr for debt repayment
• Strong anchor investor response — ~₹207 Cr raised 🔥
• Valuation looks relatively reasonable versus several listed peers
❌ Risks
• Power/EPC business is capital intensive
• Trade receivables have increased significantly ⚠️
• Business depends heavily on government & large EPC projects
• Raw-material price volatility can impact margins
• Debt remains a key factor, although IPO proceeds will reduce it
• ₹200 Cr OFS means part of the issue is existing shareholder exit
• GMP is unofficial and can change sharply before listing
🎯 My View
Lumino Industries looks like a fundamentally interesting power-infrastructure play.
🔥 Strong order book + consistent revenue/PAT growth + healthy RoE/RoCE + debt reduction plan are the biggest positives.
At the upper band, post-issue valuation is around 15.6x FY26 earnings, which looks comparatively reasonable against several listed peers.
But the key things to monitor are receivables, execution of the ₹3,149 Cr order book and cash-flow conversion.
⭐ Verdict: MAY APPLY — Listing Gains + Long Term 🚀
📌 Business Quality: ⭐⭐⭐⭐
📌 Growth Potential: ⭐⭐⭐⭐⭐
📌 Listing Gain Potential: ⭐⭐⭐⭐
📌 Risk: ⭐⭐⭐
🔥 Would you APPLY or SKIP Lumino Industries IPO?
APPLY ✅ | SKIP ❌
Comment your view 👇
⚠️ Disclaimer: This is my personal analysis, not investment advice. GMP is unofficial and can change anytime. Please do your own research before investing.
#LuminoIndustries #LuminoIPO #IPO #IPOReview #IPO2026 #PowerSector #StockMarket #Investing #NSE #BSE
🔥 ONE OF THE HOTTEST IPOs OF 2026! 🔥
🚨 Tempsens Instruments (India) IPO – ALLOTMENT UPDATE 🚨
Allotment is expected to be out soon! 👀
🤞 Fingers crossed for everyone who applied!
📌 Want to check your IPO Allotment Status?
👇 Click the link below & check your allotment:
🔗 https://t.co/u3S4rH90ZP
💬 Allotted or Not? Comment below! 👇
🚀 If you got the allotment, CONGRATULATIONS! 🥳
#TempsensInstruments #TempsensIPO #IPOAllotment #IPO2026 #IPO #StockMarket #Investing #IPOAlert
✈️ Skyways Air Services IPO Review
One of the most interesting Logistics & Air Freight IPOs of 2026! 🔥
🔷 IPO Size: ₹582.80 Cr
🔷 Price Band: ₹131 – ₹138/share
🔷 Fresh Issue: ₹398.80 Cr | OFS: ₹184 Cr
🔷 Lot Size: 100 Shares
🔷 Minimum Investment: ₹13,800
🔷 IPO Dates: 24–27 Aug 2026
🔷 Listing: 1 Sep 2026 🚀
🔷 GMP: ~₹32 (~23%)*
✅ Positives
• No. 1 air freight forwarder in India by airway bills for 4 consecutive years ✈️
• Asset-light business model — company doesn’t own aircraft
• Presence across 12 countries + 12 Indian states/UTs 🌍
• Strong exposure to India’s growing logistics & air-cargo market
• FY26 Revenue: ~₹2,840 Cr
• FY26 PAT: ~₹63.5 Cr 📈
• Revenue & profit have grown strongly over FY24–FY26
• Healthy 18.1% RoCE & 14.1% RoE
• ₹174.5 Cr raised from anchor investors, including marquee institutions 🔥 (The Economic Times)
❌ Risks
• EBITDA margin only around 4.5% — thin-margin business
• Heavy dependence on third-party airlines & freight rates
• Air freight contributes a major portion of revenue
• Borrowings increased to ~₹624 Cr by FY26
• Working-capital requirements can remain high
• Global trade, currency & geopolitical risks can impact business
• Valuation at upper band is around 49x earnings — not cheap
• OFS of ₹184 Cr means existing shareholders are also selling
🎯 My View
Skyways Air Services is an interesting growth + logistics story with a strong position in India’s air-freight forwarding market.
🔥 Strong revenue growth + improving profitability + high RoCE + No.1 positioning are definitely positives.
But this is still a thin-margin business, and the company remains dependent on airline capacity, freight rates and global trade conditions.
At ₹138, valuation isn’t cheap — so execution will be very important after listing.
⭐ Verdict: MAY APPLY — Listing Gains + Long Term 🚀
📌 Business Quality: ⭐⭐⭐⭐
📌 Growth Potential: ⭐⭐⭐⭐
📌 Listing Gain Potential: ⭐⭐⭐⭐
📌 Risk: ⭐⭐⭐⭐
🔥 Would you APPLY or SKIP Skyways Air IPO?
APPLY ✅ | SKIP ❌
Comment your view 👇
⚠️ Disclaimer: This is my personal analysis, not investment advice. GMP is unofficial and can change anytime. Please do your own research before investing.
#SkywaysAir #SkywaysAirIPO #IPO #IPOReview #IPO2026 #Logistics #StockMarket #Investing
🔥 HIND COPPER OFS ALERT! 🔥
Government is offering Hindustan Copper OFS at ₹514/share — around 10% discount to Monday’s close of ₹574! 👀
📌 Base Offer: 3% stake
📌 Green Shoe: Additional 3%
📌 Max OFS: Up to 6% stake
📌 Retail Reservation: 10%
📌 Retail Bidding: 26 Aug
📌 Settlement: 27 Aug
🚨 Why interesting?
Copper demand + strong Q1 numbers + government-backed company = interesting setup.
But remember… OFS discount ≠ guaranteed profit! Listing/price action will depend on market sentiment, copper prices & demand.
🔥 ₹514 par HINDCOPPER lena — Opportunity ya Trap?
What’s your view? 👇
SUBSCRIBE / FOLLOW for more IPO & market updates!
#HindCopper #HindustanCopper #OFS #StockMarket #Copper #NSE #BSE #Investing #Trading
⚠️ Disclaimer: This is for educational/informational purposes only. I am not a SEBI-registered investment advisor. Do your own research before taking any investment decision.
💊 Symbiotec Pharmalab IPO Review
One of the most interesting Pharma/API IPOs of 2026! 🔥
🔷 IPO Size: ₹1,757 Cr
🔷 Price Band: ₹938 – ₹988/share
🔷 Fresh Issue: ₹150 Cr | OFS: ₹1,607 Cr
🔷 Lot Size: 15 Shares
🔷 Minimum Investment: ₹14,820
🔷 IPO Dates: 24–27 Aug 2026
🔷 Listing: 1 Sep 2026 🚀
🔷 GMP: ~₹403 (~41%)*
✅ Positives
• Global player in APIs, nutritional ingredients & specialty products 💊
• Strong expertise in corticosteroid & steroidal-hormone APIs
• More than two-thirds of revenue comes from international markets 🌍
• Europe contributes around 30% of revenue
• FY26 Revenue: ~₹872 Cr
• FY26 PAT: ~₹110 Cr 📈
• EBITDA Margin around 26.6%
• IPO proceeds include repayment of around ₹112.5 Cr debt
• Strong anchor backing — ₹526 Cr raised from anchor investors 🔥
• Valuation appears more reasonable than some listed pharma peers
❌ Risks
• ₹1,607 Cr OFS is very large compared with the ₹150 Cr fresh issue
• High product concentration — top 5 products contribute around 63% of revenue
• Pharma/API business faces regulatory & pricing risks
• International exposure brings currency and geopolitical risks
• Debt remains a factor, although part of it will be repaid
• FY25 profitability was relatively flat before FY26 recovery
• GMP is unofficial and can change sharply
🎯 My View
Symbiotec is an interesting niche pharma/API story with strong global exposure and specialised products.
🔥 FY26 numbers + strong margins + anchor participation are positives.
But the huge OFS component and product concentration are the key things I would watch.
At the upper band, valuation is around 57x post-issue earnings, so this is not a cheap IPO despite looking attractive versus some pharma peers. (ipostation)
⭐ Verdict: MAY APPLY — High Risk / High Reward 🚀
📌 Business Quality: ⭐⭐⭐⭐
📌 Growth Potential: ⭐⭐⭐⭐
📌 Listing Gain Potential: ⭐⭐⭐⭐⭐
📌 Risk: ⭐⭐⭐⭐
🔥 Would you APPLY or SKIP Symbiotec Pharmalab IPO?
APPLY ✅ | SKIP ❌
Comment your view 👇
⚠️ Disclaimer: This is my personal analysis, not investment advice. GMP is unofficial and can change anytime. Please do your own research before investing.
#Symbiotec #SymbiotecPharmalab #SymbiotecIPO #IPO #IPOReview #IPO2026 #Pharma #StockMarket #Investing
🪙 Augmont Enterprises IPO Review
One of the most interesting Gold & Silver platform IPOs of 2026! 🔥
🔷 IPO Size: ₹825 Cr
🔷 Price Band: ₹750 – ₹788/share
🔷 Fresh Issue: ₹620 Cr | OFS: ₹205 Cr
🔷 Lot Size: 19 Shares
🔷 Minimum Investment: ₹14,972
🔷 IPO Dates: 21–25 Aug 2026
🔷 Listing: 28 Aug 2026 🚀
🔷 GMP: ~₹300 / ~38%
✅ Positives
• Integrated Gold & Silver ecosystem with digital + offline presence 🪙
• Augmont SPOT platform caters to jewellers, dealers & corporates
• Consumer platform gives exposure to retail gold demand
• FY26 Revenue: ~₹94,186 Cr
• FY26 PAT: ~₹348 Cr — strong YoY growth 📈
• Strong ROE of around 52% despite thin-margin bullion business
• ₹246.3 Cr raised from 14 anchor investors ahead of IPO
• Strong institutional names participated in anchor book
• Promoter stake expected to remain high post IPO
❌ Risks
• 90%+ revenue comes from Augmont SPOT → high platform concentration
• More than 63% revenue comes from Maharashtra → geographic concentration risk
• Gold/bullion business operates on very thin margins
• FY26 operating cash flow was negative (~₹42 Cr)
• Working-capital requirements can remain high
• Borrowings were around ₹243 Cr as of Dec 2025
• Valuation at upper band is not exactly cheap
• OFS of ₹205 Cr means part of the IPO is promoter/shareholder exit
🎯 My View
Augmont is an interesting but high-risk Gold & Silver play.
🔥 Strong FY26 growth + huge transaction volume + digital platform + strong anchor participation make the IPO attractive.
But investors should remember: ₹94,000+ Cr revenue does NOT mean huge margins — this is fundamentally a high-volume, low-margin bullion business.
The biggest things I would watch are cash flow, working capital, platform concentration & valuation.
⭐ Verdict: MAY APPLY — High Risk / High Reward 🚀
📌 Business Quality: ⭐⭐⭐⭐
📌 Growth Potential: ⭐⭐⭐⭐
📌 Listing Gain Potential: ⭐⭐⭐⭐
📌 Risk: ⭐⭐⭐⭐
🔥 Would you APPLY or SKIP Augmont Enterprises IPO?
Comment your view 👇
APPLY ✅ | SKIP ❌
⚠️ Disclaimer: This is my personal analysis, not investment advice. GMP is unofficial and can change anytime. Please do your own research before investing.
#AugmontEnterprises #AugmontIPO #IPO #IPOReview #IPO2026 #StockMarket #Investing #NSE #BSE
🚨 LALITHAA JEWELLERY MART IPO ALLOTMENT TODAY! 💎
Allotment is expected to be finalised TODAY, 20 Aug — could be announced anytime soon! 🔥
🔗 Click the link below & check your allotment status:
https://t.co/gTknhDb7o3
👀 Now tell me:
💎 How many LOTS did you apply for?
🎯 How many shares got allotted?
🏷️ Which category — Retail / S-HNI / B-HNI / Employee?
👇 Comment your allotment screenshot/results!
BEST OF LUCK EVERYONE! 🚀💎
#LalithaaJewellery #LalithaaJewelleryIPO #IPOAllotment #IPO #IPO2026 #StockMarket
🔥 TEMPSENS INSTRUMENTS IPO – ONE OF THE FINEST ANCHOR BOOKS 🚀
Temspens Instruments has raised a ₹194.55 Cr Anchor Book at ₹300/share with 29 Anchor Investors — and the investor mix looks seriously strong! 💰
⭐ Some BIG names in the Anchor Book:
• SBI Resurgent India Opportunities Scheme
• Nippon India Small Cap Fund
• Goldman Sachs India Equity Portfolio
• HDFC Mutual Fund – Business Cycle Fund
• HDFC Manufacturing Fund
• HDFC Innovation Fund
• Kotak Infrastructure & Economic Reform Fund
• Aditya Birla Sun Life Small Cap Fund
• Motilal Oswal Contra Fund
• 360 ONE Equity Opportunities Fund
• ValueQuest India G.I.F.T Fund
• Titanium Hybrid Long-Short Fund
• Edelweiss Recently Listed IPO Fund
• Kotak Mahindra Life Insurance
The presence of multiple reputed AMCs & institutional investors makes this one of the strongest-looking anchor books among recent IPOs. 🔥
#Tempsens #TempsensIPO #IPO #IPOIndia #StockMarket #IPOAlert
⚠️ Disclaimer: This is only my personal view for educational purposes, not investment advice. I am not a SEBI-registered investment advisor.
🚨 HORIZON INDUSTRIAL PARKS IPO – FINALLY SUBSCRIPTION COMPLETE! 🚨
Bahut mushkil se IPO bhar paya 😅🔥
Ab sabse bada sawaal — LISTING PREMIUM pe hogi ya DISCOUNT pe? 👀
📊 Final Subscription: 1.52x
🎯 Estimated Allotment Chances:
👤 Retail – 1.02x
👉 ~100% chance 😍
💼 sNII (<₹10L) – 0.70x
👉 Almost Full Allotment ✅
🏦 bNII (>₹10L) – 1.19x
👉 ~84% chance
👨💼 Employee – 1.64x
👉 ~61% chance
🏛️ QIB – 1.94x
👉 Proportionate allotment
💰 GMP around ₹1 currently suggests only a small premium (~1.7%) over ₹60 issue price, but GMP can change before listing. (India Infoline)
🔥 My View:
Subscription is not very strong, but the good thing is allotment chances look quite high, especially for Retail.
Now tell me 👇
Horizon IPO allotment ke baad HOLD karoge ya Listing pe EXIT? 🤔
#HorizonIndustrialParks #HorizonIPO #IPO #IPOAllotment #GMP #StockMarket #IPOIndia